(Q38213375)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24847164%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

title

The pathophysiology and treatment of delayed cerebral ischaemia following subarachnoid haemorrhage (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24847164%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24847164%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

5

Marek Czosnyka

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24847164%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

author name string

Karol P Budohoski

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24847164%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Mathew Guilfoyle

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24847164%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Terhi Huuskonen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24847164%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Ramez Kirollos

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24847164%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

David K Menon

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24847164%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

John D Pickard

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24847164%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Peter J Kirkpatrick

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24847164%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

language of work or name

English

0 references

publication date

20 May 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24847164%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neurology, Neurosurgery and Psychiatry

18 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24847164%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

volume

85

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24847164%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24847164%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

page(s)

1343-1353

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24847164%20AND%20SRC:MED&resulttype=core&format=json

The burden, trends, and demographics of mortality from subarachnoid hemorrhage.

18 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Time trends in outcome of subarachnoid hemorrhage: Population-based study and systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Resuscitation and critical care of poor-grade subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Quality of life in patients and partners after aneurysmal subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Predictors of cerebral infarction in aneurysmal subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: clinicoanatomic correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Prognostic factors for outcome in patients with aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Effect of statin treatment on vasospasm, delayed cerebral ischemia, and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis update

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Arteriographic demonstration of spasm of the intracranial arteries, with special reference to saccular arterial aneurysms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Transcranial Doppler for predicting delayed cerebral ischemia after subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Angiographic vasospasm is strongly correlated with cerebral infarction after subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Prediction of symptomatic vasospasm after subarachnoid hemorrhage by rapidly increasing transcranial Doppler velocity and cerebral blood flow changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Effect of cisternal and ventricular blood on risk of delayed cerebral ischemia after subarachnoid hemorrhage: the Fisher scale revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Prediction of delayed cerebral ischemia, rebleeding, and outcome after aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

A review of hemoglobin and the pathogenesis of cerebral vasospasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

DEMONSTRATION OF SUBSTANCES CAPABLE OF CONTRACTING SMOOTH MUSCLE IN THE HAEMATOMA FLUID FROM CERTAIN CASES OF RUPTURED CEREBRAL ANEURYSM

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

The pathogenetic and prognostic significance of blood-brain barrier damage at the acute stage of aneurysmal subarachnoid haemorrhage. Clinical and experimental studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Blood-brain barrier damage during the acute stage of subarachnoid hemorrhage, as exemplified by a new animal model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Increased vulnerability of the blood-brain barrier to experimental subarachnoid hemorrhage in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Inflammation and cerebral vasospasm after subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Inflammatory cytokines in subarachnoid haemorrhage: association with abnormal blood flow velocities in basal cerebral arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Endothelial dysfunction in a primate model of cerebral vasospasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Association of an endogenous inhibitor of nitric oxide synthase with cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Chronological changes of arterial diameter, cGMP, and protein kinase C in the development of vasospasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Delayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Safety and feasibility of long-term intravenous sodium nitrite infusion in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Mechanisms of disease: roles of nitric oxide and endothelin-1 in delayed cerebral vasospasm produced by aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Temporal relationship between endothelin-1 concentrations and cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Cerebrovascular characterization of clazosentan, the first nonpeptide endothelin receptor antagonist clinically effective for the treatment of cerebral vasospasm. Part I: inhibitory effect on endothelin(A) receptor-mediated contraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa stu

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Endothelin receptor antagonists for aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis update

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Relationship between vasospasm, cerebral perfusion, and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Perfusion-weighted MRI to evaluate cerebral autoregulation in aneurysmal subarachnoid haemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Regional cerebral blood flow in patients with ruptured intracranial aneurysms

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Impact of cerebral microcirculatory changes on cerebral blood flow during cerebral vasospasm after aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Does Treatment Modality of Intracranial Ruptured Aneurysms Influence the Incidence of Cerebral Vasospasm and Clinical Outcome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Impairment of cerebral perfusion and infarct patterns attributable to vasospasm after aneurysmal subarachnoid hemorrhage: a prospective MRI and DSA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Patterns of cerebral infarction in aneurysmal subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

The relationship between delayed infarcts and angiographic vasospasm after aneurysmal subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Cerebral perfusion, vascular spasm, and outcome in patients with ruptured intracranial aneurysms

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Regional cerebral blood flow studies in subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Positron Emission Tomographic Cerebral Perfusion Disturbances and Transcranial Doppler Findings among Patients with Neurological Deterioration after Subarachnoid Hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Relationship between angiographic vasospasm and regional hypoperfusion in aneurysmal subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Effect of pharmaceutical treatment on vasospasm, delayed cerebral ischemia, and clinical outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

A randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Cerebral vasospasm after subarachnoid hemorrhage: the emerging revolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Global cerebral edema after subarachnoid hemorrhage: frequency, predictors, and impact on outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Initial loss of consciousness and risk of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Acute ischemic injury on diffusion-weighted magnetic resonance imaging after poor grade subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Mechanisms of early brain injury after subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

The critical first minutes after subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Acute hypoperfusion immediately after subarachnoid hemorrhage: a xenon contrast-enhanced CT study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Intracranial pressure changes following aneurysm rupture. Part 1: clinical and angiographic correlations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Cerebral arterial flow dynamics during aneurysm haemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

"Optimal cerebral perfusion pressure" in poor grade patients after subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Characterization of microvascular basal lamina damage and blood-brain barrier dysfunction following subarachnoid hemorrhage in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Inhibition of bradykinin B2 receptors before, not after onset of experimental subarachnoid hemorrhage prevents brain edema formation and improves functional outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Cerebral inflammatory response and predictors of admission clinical grade after aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Global cerebral edema and brain metabolism after subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Early global brain oedema in relation to clinical admission parameters and outcome in patients with aneurysmal subarachnoid haemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Experimental subarachnoid hemorrhage causes early and long-lasting microarterial constriction and microthrombosis: an in-vivo microscopy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Admission angiographic cerebral circulation time may predict subsequent angiographic vasospasm after aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Luminal platelet aggregates in functional deficits in parenchymal vessels after subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Acute microvascular platelet aggregation after subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Cerebral blood flow autoregulation following subarachnoid hemorrhage in rats: chronic vasospasm shifts the upper and lower limits of the autoregulatory range toward higher blood pressures

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Continuous monitoring of cerebrovascular autoregulation after subarachnoid hemorrhage by brain tissue oxygen pressure reactivity and its relation to delayed cerebral infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Clinical significance of impaired cerebrovascular autoregulation after severe aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

A non-enzymatic derived arachidonyl peroxide, 8-iso-prostaglandin F2 alpha, in cerebrospinal fluid of patients with aneurysmal subarachnoid hemorrhage participates in the pathogenesis of delayed cerebral vasospasm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Arachidonic acid metabolism and pathophysiologic aspects of subarachnoid hemorrhage in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Oxidative stress in the human brain after subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Correlation of F4-neuroprostanes levels in cerebrospinal fluid with outcome of aneurysmal subarachnoid hemorrhage in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Oxidative stress in subarachnoid haemorrhage: significance in acute brain injury and vasospasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Vasospasm and p53-induced apoptosis in an experimental model of subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Delayed cell death related to acute cerebral blood flow changes following subarachnoid hemorrhage in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Activated autophagy pathway in experimental subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Increased cytochrome c-mediated DNA fragmentation and cell death in manganese-superoxide dismutase-deficient mice after exposure to subarachnoid hemolysate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Apoptotic mechanisms after cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Neurovascular protection reduces early brain injury after subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Cell death starts early after subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

High ICP as trigger of proinflammatory IL-6 cytokine activation in aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Pial Microcirculation in Subarachnoid Hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Morphological changes of intraparenchymal arterioles after experimental subarachnoid hemorrhage in dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Morphometry of brain parenchymal vessels following subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Early circulating levels of endothelial cell activation markers in aneurysmal subarachnoid haemorrhage: associations with cerebral ischaemic events and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Coagulative and fibrinolytic activation in cerebrospinal fluid and plasma after subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Hemostasis and fibrinolysis activation after subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Extrinsic pathway of blood coagulation and thrombin in the cerebrospinal fluid after subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Thromboembolism and delayed cerebral ischemia after subarachnoid hemorrhage: an autopsy study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Antiplatelet therapy in aneurysmal subarachnoid hemorrhage: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Cortical spreading depression causes and coincides with tissue hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Cortical spreading ischaemia is a novel process involved in ischaemic damage in patients with aneurysmal subarachnoid haemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Delayed ischaemic neurological deficits after subarachnoid haemorrhage are associated with clusters of spreading depolarizations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Delayed cerebral ischemia and spreading depolarization in absence of angiographic vasospasm after subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Recurrent spreading depolarizations after subarachnoid hemorrhage decreases oxygen availability in human cerebral cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Cerebral blood flow autoregulation in experimental subarachnoid haemorrhage in rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

The effect of experimental spasm on the CO2 response of cerebral bloodflow in primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Effect of alterations in the arterial carbon dioxide tension on the blood flow through the cerebral cortex at normal and low arterial blood pressures

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Autoregulation of cerebral blood flow during controlled hypotension in baboons

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Prediction of late ischemic complications after cerebral aneurysm surgery by the intraoperative measurement of cerebral blood flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Impairment of cerebral autoregulation predicts delayed cerebral ischemia after subarachnoid hemorrhage: a prospective observational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Cerebral autoregulation after subarachnoid hemorrhage: comparison of three methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Pressure-derived versus pressure wave amplitude-derived indices of cerebrovascular pressure reactivity in relation to early clinical state and 12-month outcome following aneurysmal subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Effects of acute treatment with statins on cerebral autoregulation in patients after aneurysmal subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Lumbar drainage of cerebrospinal fluid after aneurysmal subarachnoid hemorrhage: a prospective, randomized, controlled trial (LUMAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

EARLYDRAIN- outcome after early lumbar CSF-drainage in aneurysmal subarachnoid hemorrhage: study protocol for a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Effect on cerebral vasospasm of coil embolization followed by microcatheter intrathecal urokinase infusion into the cisterna magna: a prospective randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

A multimodal concept in patients after severe aneurysmal subarachnoid hemorrhage: results of a controlled single centre prospective randomized multimodal phase I/II trial on cerebral vasospasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Locally-administered intrathecal thrombolytics following aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/american Stroke Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Nimodipine increases fibrinolytic activity in patients with aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Systematic assessment and meta-analysis of the efficacy and safety of fasudil in the treatment of cerebral vasospasm in patients with subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Efficacy and safety of fasudil in patients with subarachnoid hemorrhage: final results of a randomized trial of fasudil versus nimodipine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Multifaceted effects of selective inhibitor of phosphodiesterase III, cilostazol, for cerebral vasospasm after subarachnoid hemorrhage in a dog model

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Cilostazol improves outcome after subarachnoid hemorrhage: a preliminary report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Effects of cilostazol on cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a multicenter prospective, randomized, open-label blinded end point trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Effect of cilostazol in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

A randomized, double-blind, placebo-controlled pilot study of simvastatin in aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Biologic effects of simvastatin in patients with aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Magnesium and its therapeutic uses: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Hypomagnesemia after aneurysmal subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

A single subcutaneous bolus of erythropoietin normalizes cerebral blood flow autoregulation after subarachnoid haemorrhage in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Beneficial effects of systemic administration of recombinant human erythropoietin in rabbits subjected to subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Acute systemic erythropoietin therapy to reduce delayed ischemic deficits following aneurysmal subarachnoid hemorrhage: a Phase II randomized, double-blind, placebo-controlled trial. Clinical article.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Effect of human albumin administration on clinical outcome and hospital cost in patients with subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

No effect of enoxaparin on outcome of aneurysmal subarachnoid hemorrhage: a randomized, double-blind, placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Reduction of ischemic sequelae following spontaneous subarachnoid hemorrhage: a double-blind, randomized comparison of enoxaparin versus placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in North America

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe, Australia, and New Zealand

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part II. A cooperative study in North America

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part I. A cooperative study in Europe, Australia, New Zealand, and South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Metaanalysis of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Neuroprotective effect of an antioxidant, ebselen, in patients with delayed neurological deficits after aneurysmal subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Effect of a free radical scavenger, edaravone, in the treatment of patients with aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Randomized, double-blind, placebo-controlled, pilot trial of high-dose methylprednisolone in aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Epidemiology of Aneurysmal Subarachnoid Hemorrhage in Australia and New Zealand

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

Antifibrinolytic Treatment in Subarachnoid Hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711

The nature of endothelium-derived vascular relaxant factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307711